Boris Gorelik
Net worth: - $ as of 31/08/2026
Net worth: - $ as of 31/08/2026
Boris Gorelik is currently VP-Business Development & Strategic Programs at Kamada Ltd. since 2022.
Formerly, Mr. Gorelik was Senior Director-Corporate Business Development at Teva Pharmaceutical Industries Ltd. and Chief Financial Officer at Nextgen Biomed Ltd. from 2016 to 2019.
Education includes undergraduate, graduate, and MBA degrees from Tel-Aviv University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KAMADA LTD -.--% | 07/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| KAMADA LTD. | Corporate Officer/Principal | 01/04/2020 |
| Companies | Position | End |
|---|---|---|
| NEXTGEN BIOMED LTD | Director of Finance/CFO | 31/07/2019 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Nextgen Biomed Ltd.
Nextgen Biomed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures skin diseases pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions